By Year : Latest  |  All  |   2024  |  2023  |  2022  |  2021  |  2020  |  2019  |  2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012

• 14 Nov 2024
  
  Changes to the Composition of Board and the Board Committees
• 14 Nov 2024
  
  Change - Announcement of Cessation :: Cessation of Independent Director
• 14 Nov 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 14 Nov 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 14 Nov 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 14 Nov 2024
  
  Cordlife Records 9M2024 Revenue Of S$19.3 Million; Group Focused On Achieving Full Resumption Of Singapore Operations
• 14 Nov 2024
  
  Q3FY2024 Press Release and Business Update
• 14 Nov 2024
  
  Replace - Extraordinary/ Special General Meeting :: Voluntary
• 10 Nov 2024
  
  Responses to Substantial and Relevant Questions from Shareholders for EGM
• 29 Oct 2024
  
  Extraordinary/ Special General Meeting :: Voluntary
• 10 Oct 2024
  
  Change of Joint Company Secretaries
• 01 Oct 2024
  
  Receipt of further notice from the MOH and Update on HTBS Licenses
• 17 Sep 2024
  
  Cordlife Unveils Enhanced Processing And Storage Facility In Singapore; Strengthens Processes As It Resumes Collection Of Cord Blood Units In A Controlled Manner
• 13 Sep 2024
  
  Further Update on Third Notice from the Ministry of Health
• 10 Sep 2024
  
  Replace - Change - Announcement of Cessation :: Resignation of Executive Officer
• 09 Sep 2024
  
  Change - Announcement of Cessation :: Resignation of Executive Officer
• 06 Sep 2024
  
  Update on Third Notice from the Ministry of Health
• 30 Aug 2024
  
  Receipt of Third Notice from the Ministry of Health
• 26 Aug 2024
  
  Update on Seventh Letter from SAC Capital Private Limited
• 25 Aug 2024
  
  Change - Announcement of Cessation :: Resignation of Executive Officer
• 19 Aug 2024
  
  Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Disclosure of Interest
• 15 Aug 2024
  
  Receipt of Notice from the Association for the Advancement of Blood & Biotherapies
• 15 Aug 2024
  
  Update on Claim against the Company
• 15 Aug 2024
  
  Change in Use of Proceeds from the Private Placement
• 15 Aug 2024
  
  Cordlife Reports 1H2024 Revenue Of S$9.2 Million After Revenue Reversal Of S$9.7 Million; Group to Focus On Growing Regional Operations
• 15 Aug 2024
  
  Financial Statements and Related Announcement :: Half Yearly Results
• 13 Aug 2024
  
  Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Becoming a Substantial Shareholder
• 12 Aug 2024
  
  Profit Warning Announcement
• 08 Aug 2024
  
  Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Becoming a Substantial Shareholder
• 05 Aug 2024
  
  Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Ceased to be a Substantial Shareholder - Margot Maclnnis
• 29 Jul 2024
  
  Update on Investigations by the Commercial Affairs Department
• 24 Jul 2024
  
  Update on Sixth Letter from SAC Capital Private Limited
• 23 Jul 2024
  
  Update on Investigations by the Commercial Affairs Department
• 22 Jul 2024
  
  Corrigendum on Announcement relating to the Appointment of Independent Director
• 17 Jul 2024
  
  Change - Announcement of Appointment :: Re-designation of Non-Independent Non-Executive Director to Group Executive Director
• 17 Jul 2024
  
  Re-designation of Non-Independent Non- Executive Director to Group Executive Director
• 25 Jun 2024
  
  UPDATE ON FIFTH LETTER FROM SAC CAPITAL PRIVATE LIMITED
• 24 Jun 2024
  
  Minutes of the Extraordinary General Meeting held on 23 May 2024
• 18 Jun 2024
  
  High Court Injunction Application Update - Notice of Discontinuance
• 18 Jun 2024
  
  Update on Notice from the Ministry of Health
• 18 Jun 2024
  
  Minutes of the Annual General Meeting held on 14 May 2024
• 11 Jun 2024
  
  Cordlife Reports 1Q2024 Performance; Charts Strategic Path To Rebuilding Foundation And Strengthening Core Processes
• 11 Jun 2024
  
  Q1FY2024 Quarterly Business Updates and Press Release
• 28 May 2024
  
  Annual Reports and Related Documents
• 28 May 2024
  
  Receipt of further notice from MOH and Update on HTBS and CLS Licenses
• 24 May 2024
  
  UPDATE ON FOURTH LETTER FROM SAC CAPITAL PRIVATE LIMITED
• 24 May 2024
  
  Changes to the Composition of Board and the Board Composition
• 24 May 2024
  
  Change of Company Secretaries, Share Registrar and Place where Register of Members and Index is kept
• 23 May 2024
  
  EXTRAORDINARY GENERAL MEETING HELD ON 23 MAY 2024 HAS BEEN ADJOURNED SINE DIE
• 23 May 2024
  
  Placements :: Termination of the Subscription Agreements
• 23 May 2024
  
  Announcement in Relation to Regulatory Actions by SGX and/or Other Authorities :: Update on Investigations by the Commercial Affairs Department
• 21 May 2024
  
  ADJOURNMENT OF THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 23 MAY 2024
• 21 May 2024
  
  Waiver :: GRANT OF FURTHER WAIVER FROM RULE 711A OF THE LISTING MANUAL
• 19 May 2024
  
  Announcement in Relation to Regulatory Actions by SGX and/or Other Authorities :: Update on Investigations by the Commercial Affairs Department
• 17 May 2024
  
  Waiver :: APPLICATION FOR FURTHER WAIVER FROM RULE 711A OF THE LISTING MANUAL
• 16 May 2024
  
  Change - Announcement of Cessation :: Removal of Non-Independent Non-Executive Director
• 15 May 2024
  
  Change - Announcement of Cessation :: Removal of Independent Director
• 15 May 2024
  
  Change - Announcement of Cessation :: Retirement of Independent Director
• 15 May 2024
  
  Replace - Change - Announcement of Appointment :: Appointment of Independent Director
• 15 May 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 15 May 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 15 May 2024
  
  Change - Announcement of Appointment :: Appointment of Independent Director
• 15 May 2024
  
  Replace - Annual General Meeting :: Voluntary
• 13 May 2024
  
  CLARIFICATION REGARDING STATUS OF APPOINTMENTS AND CESSATIONS VOTED ON AT UPCOMING AGM ON 14 MAY 24
• 13 May 2024
  
  RECEIPT OF NOTICE FROM THE MINISTRY OF HEALTH ON THE REQUIREMENTS OF THE HEALTHCARE SERVICES ACT
• 13 May 2024
  
  FURTHER UPDATE ON INTERIM INJUNCTION IN RELATION TO THE PROPOSED SUBSCRIPTION
• 10 May 2024
  
  ANNUAL GENERAL MEETING TO BE HELD ON 14 MAY 2024 RESPONSES TO SUBSTANTIAL AND RELEVANT QUESTIONS
• 10 May 2024
  
  Response to SGX Queries
• 08 May 2024
  
  Extraordinary/ Special General Meeting :: Voluntary
• 07 May 2024
  
  Cordlife Recruiting Lab & Technical Staff -Rebuild Foundation & Strengthen Singapore Core Processes
• 06 May 2024
  
  Response to SGX Queries
• 02 May 2024
  
  RECEIPT OF LETTER OF DEMAND
• 30 Apr 2024
  
  Change - Announcement of Cessation :: Retirement of Independent Non-Executive Director
• 29 Apr 2024
  
  UPDATE ON THE INTERIM INJUNCTION IN RELATION TO THE PROPOSED SUBSCRIPTION
• 29 Apr 2024
  
  Annual Reports and Related Documents
• 29 Apr 2024
  
  Notice Of Annual General Meeting
• 25 Apr 2024
  
  AUDITORS NOT SEEKING RE-APPOINTMENT AT ANNUAL GENERAL MEETING
• 25 Apr 2024
  
  Financial Statements and Related Announcement :: Auditor's Comments of Accounts
• 25 Apr 2024
  
  Financial Statements and Related Announcement :: Discrepancies between unaudited and audited accounts
• 24 Apr 2024
  
  Update on Third Letter from SAC Capital Private Limited
• 22 Apr 2024
  
  HIGH COURT INJUNCTION APPLICATION AND INTERIM INJUNCTION IN RELATION TO THE PROPOSED SUBSCRIPTION
• 17 Apr 2024
  
  Lodgement of Police Report
• 17 Apr 2024
  
  Placements :: PROPOSED PLACEMENT OF UP TO 51,195,478 NEW ORDINARY SHARES IN THE CAPITAL OF THE COMPANY
• 16 Apr 2024
  
  Waiver :: Grant of Extensions of Time by ACRA under Sections 175 and 197 of Companies Act 1967 of Singapore
• 15 Apr 2024
  
  Waiver :: Grant of Waivers from Rules 707(1) and 711A of the Listing Manual
• 11 Apr 2024
  
  Waiver :: Application for Waivers from Rules 707(1), 707(2) and 711A of the Listing Manual
• 08 Apr 2024
  
  Update on Testing Results for Tanks Under Investigation
• 08 Apr 2024
  
  Further Extension of Trading Halt
• 05 Apr 2024
  
  Announcement in Relation to Regulatory Actions by SGX and/or Other Authorities :: Update on Investigations by The Commercial Affairs Department
• 05 Apr 2024
  
  Further Extension of Trading Halt
• 04 Apr 2024
  
  Extension of Trading Halt
• 04 Apr 2024
  
  Updates on Requisition Notices
• 27 Mar 2024
  
  Announcement in Relation to Regulatory Actions by SGX and/or Other Authorities :: Updates on the Investigations by the Commercial Affairs Department
• 27 Mar 2024
  
  Receipt of Third Requisition Notice
• 24 Mar 2024
  
  Update on Requisition Notices
• 22 Mar 2024
  
  Letter to Shareholders
• 22 Mar 2024
  
  Announcement in Relation to Regulatory Actions by SGX and/or Other Authorities :: Investigations by The Commercial Affairs Department
• 21 Mar 2024
  
  Receipt of Requisition Notices and Further Extension of Trading Halt
• 20 Mar 2024
  
  Extension of Trading Halt
• 29 Feb 2024
  
  Change - Change in Corporate Information :: Announcement pursuant to Rule 706A of the SGX-ST Listing Manual
• 29 Feb 2024
  
  Cordlife's FY2023 Net Profit Decreased 23.1% To S$3.8 Million
• 29 Feb 2024
  
  Financial Statements and Related Announcement :: Full Yearly Results
• 29 Feb 2024
  
  Further Update to Announcement on Appointment of Mr Yiu Pang Fai as CEO & Response to Media Article
• 29 Feb 2024
  
  Changes in the Composition of the Board and Board Committees
• 28 Feb 2024
  
  Change - Announcement of Cessation :: Resignation of Executive Director and Group CEO
• 27 Feb 2024
  
  Financial Statements and Related Announcement :: Profit Guidance
• 19 Feb 2024
  
  Appointment of Mr Yiu Pang Fai as Group CEO & Further Update to Announcement Released on 27 Oct 2023
• 19 Feb 2024
  
  Change - Announcement of Appointment :: Appointment of Group CEO
• 25 Jan 2024
  
  Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) :: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
• 23 Jan 2024
  
  Receipt of Letter from the Ministry of Health
• 17 Jan 2024
  
  Response to Media Article and Update on Tanks under Investigation